210 related articles for article (PubMed ID: 2137287)
1. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
[TBL] [Abstract][Full Text] [Related]
2. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient.
Tanaka A; Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 Oct; 156(2):1015-9. PubMed ID: 2973311
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for the "DN allele" (G533-greater than A) of the beta-hexosaminidase alpha subunit gene identified by direct DNA sequencing in a family with the B1 variant of GM2-gangliosidosis.
Whitley CB; Anderson RA; McIvor RS
Neuropediatrics; 1992 Apr; 23(2):96-101. PubMed ID: 1318511
[TBL] [Abstract][Full Text] [Related]
5. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal.
dos Santos MR; Tanaka A; sá Miranda MC; Ribeiro MG; Maia M; Suzuki K
Am J Hum Genet; 1991 Oct; 49(4):886-90. PubMed ID: 1832817
[TBL] [Abstract][Full Text] [Related]
6. A double mutation in exon 6 of the beta-hexosaminidase alpha subunit in a patient with the B1 variant of Tay-Sachs disease.
Ainsworth PJ; Coulter-Mackie MB
Am J Hum Genet; 1992 Oct; 51(4):802-9. PubMed ID: 1415222
[TBL] [Abstract][Full Text] [Related]
7. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
[TBL] [Abstract][Full Text] [Related]
8. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
Navon R; Proia RL
Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the invariant AG of the acceptor splice site of intron 4 of the beta-hexosaminidase alpha-subunit gene in two unrelated American black GM2-gangliosidosis (Tay-Sachs disease) patients.
Mules EH; Dowling CE; Petersen MB; Kazazian HH; Thomas GH
Am J Hum Genet; 1991 Jun; 48(6):1181-5. PubMed ID: 1827945
[TBL] [Abstract][Full Text] [Related]
10. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
[TBL] [Abstract][Full Text] [Related]
11. A new point mutation within exon 5 of beta-hexosaminidase alpha gene in a Japanese infant with Tay-Sachs disease.
Nakano T; Nanba E; Tanaka A; Ohno K; Suzuki Y; Suzuki K
Ann Neurol; 1990 May; 27(5):465-73. PubMed ID: 2141777
[TBL] [Abstract][Full Text] [Related]
12. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
[TBL] [Abstract][Full Text] [Related]
13. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
14. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
[TBL] [Abstract][Full Text] [Related]
15. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Moskowitz SM; Uhrhammer N; Wright N; Kaback MM; Neufeld EF
J Biol Chem; 1990 Jun; 265(16):9452-7. PubMed ID: 2140574
[TBL] [Abstract][Full Text] [Related]
16. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
Fernandes MJ; Hechtman P; Boulay B; Kaplan F
Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
[TBL] [Abstract][Full Text] [Related]
17. A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation.
Fernandes M; Kaplan F; Natowicz M; Prence E; Kolodny E; Kaback M; Hechtman P
Hum Mol Genet; 1992 Dec; 1(9):759-61. PubMed ID: 1302612
[TBL] [Abstract][Full Text] [Related]
18. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
Navon R; Proia RL
Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
[TBL] [Abstract][Full Text] [Related]
19. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease.
Richard MM; Erenberg G; Triggs-Raine BL
Biochem Mol Med; 1995 Jun; 55(1):74-6. PubMed ID: 7551830
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Kaback MM; Neufeld EF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
